155 related articles for article (PubMed ID: 38265948)
1. Cancer biomarkers: Clinical aspects & laboratory determination.
Gupta SK
Indian J Med Res; 2023 Nov; 158(5&6):565-566. PubMed ID: 38265948
[No Abstract] [Full Text] [Related]
2. Cancer biomarkers.
Kucuk O
Mol Aspects Med; 2015 Nov; 45():1-2. PubMed ID: 26187107
[No Abstract] [Full Text] [Related]
3. Biomarkers: diagnostic highlights and surrogate end points. Cambridge Healthtech Institute's biomarker series: biomarker validation: bringing discovery to the clinic & cancer biomarkers: from discovery to clinical practice. May 3-5, 2004, Philadelphia, Pennsylvania, USA.
Levenson VV
Pharmacogenomics; 2004 Jul; 5(5):459-61. PubMed ID: 15212582
[No Abstract] [Full Text] [Related]
4. Biomarkers are hot.
Gullans SR
Biotechniques; 2005 Apr; Suppl():7. PubMed ID: 16528917
[No Abstract] [Full Text] [Related]
5. Cancer Diagnostic and Predictive Biomarkers 2018.
Buonaguro FM; Caposio P; Tornesello ML; De Re V; Franco R
Biomed Res Int; 2019; 2019():3879015. PubMed ID: 30729121
[No Abstract] [Full Text] [Related]
6. Preface: special issue on microRNAs as novel cancer biomarkers and therapeutic targets.
Zaffaroni N
Crit Rev Oncog; 2013; 18(4):v-vi. PubMed ID: 23614623
[No Abstract] [Full Text] [Related]
7. Emerging trends in biomarker discovery: Ease of prognosis and prediction in cancer.
Sharma AK
Semin Cancer Biol; 2018 Oct; 52(Pt 1):iii-iv. PubMed ID: 29857038
[No Abstract] [Full Text] [Related]
8. Special Issue: Molecular Biomarkers in Solid Tumors.
Fusco N; Marchiò C; Ghidini M; Scatena C
Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34203156
[TBL] [Abstract][Full Text] [Related]
9. [Great potential of miRNAs as predictive and prognostic markers for cancer].
Cho WC
Zhongguo Fei Ai Za Zhi; 2013 Jan; 16(1):C1-4. PubMed ID: 23677001
[No Abstract] [Full Text] [Related]
10. DoCM: a database of curated mutations in cancer.
Ainscough BJ; Griffith M; Coffman AC; Wagner AH; Kunisaki J; Choudhary MN; McMichael JF; Fulton RS; Wilson RK; Griffith OL; Mardis ER
Nat Methods; 2016 Sep; 13(10):806-7. PubMed ID: 27684579
[No Abstract] [Full Text] [Related]
11. Illumina, Thermo Fisher build consortia to develop 'universal' cancer tests.
Morrison C
Nat Biotechnol; 2014 Nov; 32(11):1073-4. PubMed ID: 25380427
[No Abstract] [Full Text] [Related]
12. Non-coding RNAs in human cancer.
Peng Y
Semin Cancer Biol; 2021 Oct; 75():1-2. PubMed ID: 33894382
[No Abstract] [Full Text] [Related]
13. microRNAs as cancer biomarkers.
Flatmark K; Høye E; Fromm B
Scand J Clin Lab Invest Suppl; 2016; 245():S80-3. PubMed ID: 27542003
[TBL] [Abstract][Full Text] [Related]
14. Cell-Free Nucleic Acids.
Nagy B
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31718077
[TBL] [Abstract][Full Text] [Related]
15. Translational genomics: the challenge of developing cancer biomarkers.
Brooks JD
Genome Res; 2012 Feb; 22(2):183-7. PubMed ID: 22301132
[TBL] [Abstract][Full Text] [Related]
16. Involvement of miRNAs and Pseudogenes in Cancer.
Tutar L; Özgür A; Tutar Y
Methods Mol Biol; 2018; 1699():45-66. PubMed ID: 29086367
[TBL] [Abstract][Full Text] [Related]
17. Artifacts marr the genetic signature of cancer.
Wong J
Lancet Oncol; 2013 Aug; 14(9):e344. PubMed ID: 24058964
[No Abstract] [Full Text] [Related]
18. MicroRNA signatures in cytopathology: Are they ready for prime time?
Beca F; Schmitt F
Cancer Cytopathol; 2016 Sep; 124(9):613-5. PubMed ID: 27153190
[No Abstract] [Full Text] [Related]
19. Long Noncoding RNA Signatures as Cancer Biomarkers.
Mas AM; Huarte M
J Clin Oncol; 2023 Jun; 41(16):3059-3062. PubMed ID: 37043713
[No Abstract] [Full Text] [Related]
20. [Circular RNA, actors and biomarkers of cancers].
Ladet J; Mortreux F
Med Sci (Paris); 2020 Oct; 36(10):935-938. PubMed ID: 33026338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
